# FDA recall D-0875-2023

> **AVKARE LLC** · Class III · drug recall initiated 2023-06-13.

## Product

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13

## Reason for recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0875-2023
- **Recalling firm:** AVKARE LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-06-13
- **Report date:** 2023-06-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pulaski, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0875-2023

## Citation

> AI Analytics. FDA recall D-0875-2023. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0875-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*